Immune checkpoint inhibitor-related acral vasculitis

Immune checkpoint inhibitor-related acral vasculitis

Abstract Commentary on « Ipilimumab induced vasculitis » by Padda A. et al., J Immunother Cancer. 2018;6:12. The authors diagnosed a small vessel vasculitis following treatment with anti-CTLA-4 (ipilimumab) for a resected stage III B/C melanoma. We report a similar case of acral vasculitis occurring...

Full description

Bibliographic Details
Main Authors: Thibault Comont, Vincent Sibaud, Loïc Mourey, Pierre Cougoul, Odile Beyne-Rauzy
Format: Article
Language:English
Published: BMJ Publishing Group 2018-11-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Immune check point inhibitors
Immune-related adverse events
Vasculitis
Online Access:http://link.springer.com/article/10.1186/s40425-018-0443-6

Internet

http://link.springer.com/article/10.1186/s40425-018-0443-6

Similar Items